市場調查報告書

動物用分子診斷的全球市場 - 成長,趨勢,預測(2019年∼2024年)

Veterinary Molecular Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 851242
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
Back to Top
動物用分子診斷的全球市場 - 成長,趨勢,預測(2019年∼2024年) Veterinary Molecular Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年04月01日內容資訊: 英文 114 Pages
簡介

由於畜產業的發展,及寵物的社會地位的變化等,對迅速可靠性高的診斷技術的需求高漲。在美國,2018年報告人口的60%以上擁有寵物。由於飼養寵物作為家族一員的寵物家族化的趨勢高漲也提高動物醫療的需求。

本報告提供動物用分子診斷的世界市場調查,市場概要,各產品、用途、技術、地區的市場規模的變化與預測,市場成長要素及課題分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 成長要素
    • 動物疾病的罹患率上升
    • 動物來源蛋白質的需求增加
    • 動物的醫療費用支出的增加
  • 阻礙因素
    • 熟練技能者的不足
    • 診斷檢驗的成本高
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第5章 市場區隔

  • 各產品
    • 設備
    • 套件、試劑
    • 軟體、服務
  • 各用途
    • 感染疾病
    • 遺傳學
    • 其他
  • 各技術
    • PCR(聚合酵素鏈鎖反應)
    • 微陣列
    • DNA定序
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Biochek BV
    • Biomerieux SA
    • Bioneer Corporation
    • Idexx Laboratories Inc.
    • Ingenetix GmbH
    • Neogen Corporation
    • Thermo Fischer Scientific Inc.
    • Veterinary Molecular Diagnostics Inc.

第7章 市場機會及未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 64809

Market Overview

  • Developments in the animal farming sector and changing societal attitude toward pet animals have resulted in an increased demand for fast and reliable diagnostic techniques. Molecular diagnostics possess the potential to address this growing demand. As of 2018, more than 60% of the US population owned a pet/companion animal. There is an increasing trend of treating pets as family members, which has increased the healthcare demands for veterinary applications. Additionally, there is a booming market for molecular diagnostics technology in the United States. The players in the molecular diagnostics market are expanding to provide services beyond human applications in the form of animal diagnostics.
  • The increasing pet population is one of the reasons for the rising health expenditure on animals, globally. As per the estimates of the American Pet Products Association, the total American pet industry expenditure is expected to reach USD 75.38 billion by end 2019, up from USD 72.56 billion in 2018. The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for animals, for various disease conditions.
  • Furthermore, there is an increase in the livestock population, owing to the huge demand for animal-derived products. This is expected to increase the demand for molecular diagnostic tests in the next coming years.

Scope of the Report

Veterinary molecular diagnostics refer to the molecular diagnostic techniques that are employed to analyze samples originating from animals (companion, domestic, etc.). Veterinary molecular diagnostics primarily focuses on the detection, identification, and genotyping of pathogens.

Key Market Trends

The Kits and Reagents Segment is Expected to Register Robust Growth During The Forecast Period

Majority of the commercial products in the global veterinary molecular diagnostics market are available in the form of kits. These kits are predominantly based on PCR techniques and help in the screening of a family of related disorders. The kits based on microarrays are steadily increasing their market share. Over the forecast period, many products based on immune-assays are expected to receive marketing approval. There are several assays linked to pathogen and viruses detection, which are combined with the PCR techniques, such as Porcine Epidemic Diarrhea Virus (PEDv), Porcine Deltacoronavirus (PDCoV), and Transmissible Gastroenteritis Virus (TGEV). Different companies have specialization and resources restricted for assays to be useful for a certain category of animals, which is among the major challenge for the use of molecular diagnostics. However, over the forecast period, the kits and reagent segment is poised to register rapid growth, due to the growing trend of performing tests at the large scale across multiple hospitals.

North America is Expected to Retain the Largest Share in the Market

In 2018, North America had the largest share in the market studied. Additionally, the North American region is expected to exhibit the highest growth rate over the forecast period. This is primarily due to the increasing trend of pet ownership in the region and rising demand for animal-based proteins in the region. The United States is expected to retain its significant market share, owing to factors, such as rising pet adoption and increasing per capita animal healthcare expenditure. In addition, the rise in the prevalence of various animal diseases and injuries has been identified as the major factor fueling market growth.

Competitive Landscape

There are several well-established companies operating in the global market, with diagnostics kits and reagents specific to molecular diagnostics, such as IDEXX. The vet provides its customer with a range of products to simplify real-time PCR testing, including kits for sample preparation, extraction, and amplification.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Prevalence of Animal Diseases
    • 4.2.2 Increase in Demand for Animal-derived Proteins
    • 4.2.3 Growth in Animal Health Expenditure
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Personnel
    • 4.3.2 High Cost of Diagnostic Tests
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Instruments
    • 5.1.2 Kit and Reagents
    • 5.1.3 Software and Services
  • 5.2 By Application
    • 5.2.1 Infectious Diseases
    • 5.2.2 Genetics
    • 5.2.3 Other Applications
  • 5.3 By Technology
    • 5.3.1 PCR
    • 5.3.2 Microarray
    • 5.3.3 DNA Sequencing
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Biochek BV
    • 6.1.2 Biomerieux SA
    • 6.1.3 Bioneer Corporation
    • 6.1.4 Idexx Laboratories Inc.
    • 6.1.5 Ingenetix GmbH
    • 6.1.6 Neogen Corporation
    • 6.1.7 Thermo Fischer Scientific Inc.
    • 6.1.8 Veterinary Molecular Diagnostics Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top